Changes in Antigen Carbohydrate 125 in Patients Receiving Dapagliflozin following an Admission for Acute Heart Failure
Introduction: Antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload and inflammation in acute heart failure (AHF). We aimed to evaluate the influence of dapagliflozin on CA125 levels within the first weeks after discharge and whether CA125 changes were related to 6-mon...
Saved in:
| Main Authors: | Gema Miñana, Rafael de la Espriella, Miguel Lorenzo-Hernández, Enrique Rodriguez-Borja, Anna Mollar, Patricia Palau, Agustin Fernández-Cisnal, Ernesto Valero, Arturo Carratalá, Enrique Santas, Vicent Bodi, Juan Sanchis, Antoni Bayés-Genís, Eduardo Nuñez, Julio Nuñez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-01-01
|
| Series: | Cardiorenal Medicine |
| Online Access: | https://karger.com/article/doi/10.1159/000543417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers to Improve Decision-making in Acute Heart Failure
by: Rafael de la Espriella, et al.
Published: (2023-10-01) -
The DELIVER Trial: The Beginning of the End of Ejection Fraction Tyranny
by: Antoni Bayes-Genis
Published: (2022-12-01) -
Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure
by: Marko Kumric, et al.
Published: (2021-12-01) -
Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction
by: Sher May Ng, et al.
Published: (2025-10-01) -
Paradox of Low CA-125 in Patients with Decompensated Congestive Heart Failure
by: Raquel López-Vilella, et al.
Published: (2025-07-01)